Javascript must be enabled to continue!
Myelodysplasia
View through CrossRef
Myelodysplasia comprises a group of clonal haematopoietic stem cell disorders characterized by cytopenia and dysplasia in one or more cell lineage(s), and a tendency to evolve to acute myeloid leukaemia. Myelodysplasia is much rarer in children than in adults. This chapter describes the epidemiology, classification, clinical features and management of myelodysplasia in children which differs considerably from that in adults. Juvenile myelomonocytic leukaemia is regarded as a myelodyplastic / myeloproliferative disease and is unique to childhood. Supportive care is important for all children with myelodysplasia. Whilst a few children with low grade myelodysplasia may be managed with observation only, most children with advanced myelodysplasia and juvenile myelomonocytic leukaemia require haemopoietic stem cell transplantation.
Title: Myelodysplasia
Description:
Myelodysplasia comprises a group of clonal haematopoietic stem cell disorders characterized by cytopenia and dysplasia in one or more cell lineage(s), and a tendency to evolve to acute myeloid leukaemia.
Myelodysplasia is much rarer in children than in adults.
This chapter describes the epidemiology, classification, clinical features and management of myelodysplasia in children which differs considerably from that in adults.
Juvenile myelomonocytic leukaemia is regarded as a myelodyplastic / myeloproliferative disease and is unique to childhood.
Supportive care is important for all children with myelodysplasia.
Whilst a few children with low grade myelodysplasia may be managed with observation only, most children with advanced myelodysplasia and juvenile myelomonocytic leukaemia require haemopoietic stem cell transplantation.
Related Results
Clinical Implications of Cytopenias in the U.S. Immunodeficiency Network Registry
Clinical Implications of Cytopenias in the U.S. Immunodeficiency Network Registry
Rationale
The correlation between cytopenias and infection, malignancy, and mortality has not been systematically characterized in patients with inborn errors of ...
Cerebrospinal Fluid Shunt Complications after Urological Procedures in Children with Myelodysplasia
Cerebrospinal Fluid Shunt Complications after Urological Procedures in Children with Myelodysplasia
ABSTRACT
OBJECTIVE
Invasive urological procedures, commonly performed on patients with myelodysplasia, may contribute to the occ...
Olaparib-induced myelodysplasia – A case report
Olaparib-induced myelodysplasia – A case report
Olaparib is an antineoplastic agent that is a poly ADP ribose polymerase (PARP) inhibitor and is Food and Drug Administration-approved for the treatment of ovarian, breast, pancrea...
HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.
HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.
Abstract
Background: Dysregulation and overexpression of the tumorigenic gene HMGA2 has been demonstrated in the mononuclear cells of 12 consecutive MMM patients (pt...
Cytogenetic and molecular diagnosis of chromosome 5 deletions in myelodysplasia
Cytogenetic and molecular diagnosis of chromosome 5 deletions in myelodysplasia
Deletions of chromosome 5, del(5q), are frequently observed in myelodysplasia (MDS). We evaluated molecular detection of loss of heterozygosity (LOH) as a diagnostic method to dete...
Hematological Abnormalities in Copper Deficiency.
Hematological Abnormalities in Copper Deficiency.
Abstract
Introduction: Copper deficiency can rarely present as anemia and leucopenia. Copper and iron are essential trace elements through their functions as co-fact...
Present status and perspective of laboratory hematology in Japan: On the standardization of blood cell morphology including myelodysplasia: On behalf of the Japanese Society for Laboratory Hematology
Present status and perspective of laboratory hematology in Japan: On the standardization of blood cell morphology including myelodysplasia: On behalf of the Japanese Society for Laboratory Hematology
AbstractThe Japanese Society for Laboratory Hematology (JSLH) was launched in 2000 and has been developed by a mutual collaboration of hematologists, medical technologists, and the...
Chronic Myelomonocytic Leukemia Presenting With Polyserositis and Seropositivity for Rheumatoid Arthritis
Chronic Myelomonocytic Leukemia Presenting With Polyserositis and Seropositivity for Rheumatoid Arthritis
Chronic myelomonocytic leukemia (CMML) is a rare clonal stem cell disorder associated with clinical and pathologic of myelodysplasia and myeloproliferation. Systemic autoimmune/inf...

